CORRADINI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 1.692
EU - Europa 1.476
AS - Asia 1.159
SA - Sud America 225
AF - Africa 36
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.598
Nazione #
US - Stati Uniti d'America 1.627
IT - Italia 716
CN - Cina 387
SG - Singapore 312
BR - Brasile 142
DE - Germania 108
JP - Giappone 104
FR - Francia 93
VN - Vietnam 87
ES - Italia 79
SE - Svezia 63
IE - Irlanda 61
TR - Turchia 59
GB - Regno Unito 58
PL - Polonia 46
CA - Canada 38
IN - India 34
NL - Olanda 33
RU - Federazione Russa 31
FI - Finlandia 29
CO - Colombia 28
KR - Corea 26
AR - Argentina 25
AT - Austria 24
HK - Hong Kong 22
GR - Grecia 20
MX - Messico 20
ID - Indonesia 18
IL - Israele 18
CH - Svizzera 16
RO - Romania 16
UA - Ucraina 16
BE - Belgio 12
CL - Cile 12
IQ - Iraq 12
TN - Tunisia 11
JO - Giordania 10
TW - Taiwan 9
EC - Ecuador 8
MY - Malesia 8
PT - Portogallo 8
TH - Thailandia 8
AU - Australia 7
BD - Bangladesh 7
HU - Ungheria 7
IR - Iran 7
MA - Marocco 7
MK - Macedonia 6
PH - Filippine 6
RS - Serbia 6
SA - Arabia Saudita 6
SN - Senegal 5
HR - Croazia 4
NO - Norvegia 4
PE - Perù 4
PS - Palestinian Territory 4
ZA - Sudafrica 4
AL - Albania 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
KE - Kenya 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
UZ - Uzbekistan 3
EG - Egitto 2
JM - Giamaica 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
TG - Togo 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.598
Città #
Singapore 171
Ashburn 128
Chandler 99
Fairfield 95
Beijing 87
San Jose 87
Santa Clara 80
Rome 75
Redwood City 69
Houston 62
Dublin 60
Woodbridge 54
Milan 53
Seattle 46
Torino 41
Wilmington 40
Turin 36
Tokyo 35
Guangzhou 28
Cambridge 27
Nyköping 26
Los Angeles 25
Lauterbourg 24
Ho Chi Minh City 22
Seoul 22
São Paulo 22
Shanghai 21
Columbus 20
Florence 20
Hefei 20
Helsinki 20
Ann Arbor 19
Hanoi 19
Munich 19
Pisa 19
The Dalles 19
Hangzhou 18
New York 18
Bologna 17
Hong Kong 17
Madrid 17
Villeurbanne 17
Ankara 16
Dallas 16
London 16
Jacksonville 15
Dearborn 14
Medford 14
Warsaw 14
Athens 13
Barcelona 13
Princeton 13
Rochester 13
Tianjin 13
Chiyoda-ku 12
Genova 12
Parma 12
Frankfurt am Main 11
Medellín 11
Vienna 11
Amsterdam 10
Bengaluru 10
Duncan 10
Jakarta 10
Zhengzhou 10
Bethesda 9
Buenos Aires 9
Dong Ket 9
Düsseldorf 9
Istanbul 9
Jerusalem 9
Moscow 9
Wuhan 9
Xian 9
Belém 8
Boston 8
Council Bluffs 8
Orem 8
Ottawa 8
Palermo 8
San Mateo 8
Toronto 8
Trieste 8
Brussels 7
Buffalo 7
Hamburg 7
Napoli 7
Nauka 7
Newtown Square 7
Paris 7
Brescia 6
Granada 6
Guayaquil 6
Hebei 6
Memphis 6
Osaka 6
Philadelphia 6
Phoenix 6
Santiago 6
Serra 6
Totale 2.365
Nome #
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 1.513
Predicting failure of hematopoietic stem cell mobilization before it starts: the Predicted Poor Mobilizer (pPM) score 593
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 505
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results 313
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 229
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation 199
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma 199
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL) 140
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma 129
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 110
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma 109
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer 109
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia 101
New treatment strategies for elderly myeloma patients 96
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 94
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients 92
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer 89
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study 40
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term 18
Totale 4.678
Categoria #
all - tutte 11.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 0 31 28
2021/2022405 26 35 13 44 38 26 38 21 31 24 73 36
2022/2023468 29 45 22 42 34 74 24 43 50 27 50 28
2023/2024350 26 40 32 39 26 44 23 12 19 31 31 27
2024/2025710 23 28 50 60 122 60 25 54 105 37 45 101
2025/2026977 112 66 74 113 121 44 159 46 97 102 43 0
Totale 4.678